We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-3.4%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+505.55%
AUM
$396B
AUM Growth
-$4.47B
Cap. Flow
+$17.3B
Cap. Flow %
4.36%
Top 10 Hldgs %
17.57%
Holding
6,885
New
459
Increased
2,707
Reduced
2,368
Closed
646

Sector Composition

Rank Sector Weight
1 Technology 15.47%
2 Healthcare 9.44%
3 Financials 9.02%
4 Consumer Discretionary 7.88%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCAW
5801
DELISTED
Capitalworks Emerging Markets Acquisition Corp Warrant
CMCAW
$20K ﹤0.01%
220,449
GRTX
5802
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$20K ﹤0.01%
11,455
-182
-2% -$257
NCACW
5803
DELISTED
Newcourt Acquisition Corp Warrant
NCACW
$20K ﹤0.01%
304,217
ALLG.WS
5804
DELISTED
Allego N.V. Warrants
ALLG.WS
$20K ﹤0.01%
43,451
+250
+0.6% +$105
GOGN.WS
5805
DELISTED
GoGreen Investments Corporation Redeemable Warrants
GOGN.WS
$20K ﹤0.01%
157,654
AGGRW
5806
DELISTED
Agile Growth Corp Warrant
AGGRW
$20K ﹤0.01%
458,239
TLGYW
5807
DELISTED
TLGY Acquisition Corporation Warrant
TLGYW
$20K ﹤0.01%
249,343
ARDX icon
5808
Ardelyx
ARDX
$1.21B
$19K ﹤0.01%
16,055
-318,258
-95% -$303K
DRRX
5809
DELISTED
DURECT Corp
DRRX
$19K ﹤0.01%
3,370
-33,769
-91% -$206K
ERNA icon
5810
Eterna Therapeutics
ERNA
$4.78M
$19K ﹤0.01%
10
-3
-23% -$10.3K
VINC
5811
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$19K ﹤0.01%
695
-1,111
-62% -$32K
OHAAW
5812
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$19K ﹤0.01%
179,044
TRCA.WS
5813
DELISTED
Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TRCA.WS
$19K ﹤0.01%
309,716
RUBY
5814
DELISTED
Rubius Therapeutics, Inc
RUBY
$19K ﹤0.01%
44,521
-234,387
-84% -$176K
DAOOW
5815
DELISTED
Crypto 1 Acquisition Corp Warrants
DAOOW
$19K ﹤0.01%
192,408
EMKR
5816
DELISTED
Emcore Corp
EMKR
$19K ﹤0.01%
1,123
-2,448
-69% -$65.4K
BOLT icon
5817
Bolt Biotherapeutics
BOLT
$7.59M
$18K ﹤0.01%
607
-1,081
-64% -$44.7K
TNXP icon
5818
Tonix Pharmaceuticals
TNXP
$179M
$18K ﹤0.01%
2
+1
+100% +$24.5K
BOCNW
5819
DELISTED
Blue Ocean Acquisition Corp Warrants
BOCNW
$18K ﹤0.01%
160,443
APXIW
5820
DELISTED
APx Acquisition Corp. I Warrant
APXIW
$18K ﹤0.01%
262,102
GLS
5821
DELISTED
Gelesis Holdings, Inc.
GLS
$18K ﹤0.01%
16,472
-22,747
-58% -$30.1K
BYSI icon
5822
BeyondSpring
BYSI
$40.1M
$17K ﹤0.01%
17,599
-88,036
-83% -$125K
CNTB
5823
Connect Biopharma Holdings
CNTB
$137M
$17K ﹤0.01%
13,497
-5,956
-31% -$7.16K
LCTX icon
5824
Lineage Cell Therapeutics
LCTX
$284M
$17K ﹤0.01%
15,473
-64,696
-81% -$95K
TROO icon
5825
TROOPS Inc
TROO
$241M
$17K ﹤0.01%
+15,971
New +$32.4K

Similar funds

Goldman Sachs's Q3 2022 Portfolio in Review

As of Q3 2022, Goldman Sachs held 6,885 positions worth $396B, down 1.1% from $400B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Goldman Sachs deployed $17.3B of net new capital in Q3 2022, opening 459 new positions and adding to 2,707 existing holdings. Its largest new stake was Schwab US TIPS ETF: 8,348,958 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $930M trimmed.

  • Goldman Sachs's largest Q3 2022 buy was Schwab US TIPS ETF: 8,348,958 shares worth $216M.
  • Goldman Sachs added most to Visa in Q3 2022, an estimated $2.06B increase.
  • Goldman Sachs's biggest Q3 2022 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $930M.
  • Goldman Sachs fully exited Mandiant, Inc. Common Stock in Q3 2022, selling an estimated $236M.
  • Goldman Sachs's ten largest holdings make up 18% of its $396B portfolio in Q3 2022.
  • Goldman Sachs opened 459 new positions and closed 646 in Q3 2022.
  • Goldman Sachs's portfolio value fell 1.1% quarter-over-quarter to $396B.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.